Olympia Pharmacy Recalls Trimix Due to Sterility Concerns
Olympia Pharmacy is recalling 24 units of compounded Trimix nationwide and in Puerto Rico due to FDA inspection findings regarding quality control and sterility assurance.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score involving quality control concerns without confirmed harm.
Plain-English summary
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling 24 units of compounded Trimix. The product was distributed nationwide and in Puerto Rico. The recall is being conducted due to FDA inspection findings that raised concerns regarding quality control processes and the assurance of sterility.
The recall covers specific lots with expiration dates ranging from June 2013 to September 2013. The source text does not report any illnesses or injuries associated with the use of this product.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for instructions on how to dispose of the medication.
The recalled product
- Product
- Trimix, compounded by Olympia Pharmacy, Orlando, FL
- Manufacturer
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Category
- Drug — Compounded Medication
- Hazard
- Affected units
- 24
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- B5015 Exp 8/15/13
- C50001 Exp 8/28/13
- B5011 Exp 8/1/13
- C42215 Exp 6/22/13
- A5028 Exp 6/2/13
- B5011 Exp 6/1/13
- B5020 Exp 6/1/13
- B50112 Exp 8/11/13
- C4186 Exp 6/18/13
- C4158 Exp 6/15/13
- C4149 Exp 6/14/13
- C4111 Exp 6/11/13
- B4124 Exp 8/12/13
- B4154 Exp 8/15/13
- B4198 Exp 8/19/13
- B4226 Exp 8/22/13
- B4268 Exp 8/22/13
- C40522 Exp 9/5/13
- C4118 Exp 9/1/13
- C4711 Exp 9/7/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 105 recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 105 products in this recall →Related recalls
Same manufacturer · Lowlite Investments, Inc. D/B/A Olympia Pharmacy
See all →- SevereOlympia Pharmacy Recalls Diclazuril Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- HighOlympia Pharmacy Recalls Metabolase Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Betamethasone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls HACC 270.1 Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
Same hazard · sterility concern
See all →- HighSegmental Stem Components for ELEOS Limb Salvage System Recalled
FDA (Devices) · 2025-06-04
- HighMEDIHONEY Dressing Applicator Pouch Recalled for Sterility Concerns
FDA (Devices) · 2024-10-16
- HighProparacaine Hydrochloride Eye Drops Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-10-02
- HighExactech OPTETRAK Knee Implants Recalled for Out-of-Specification Vacuum Bag Packaging
FDA (Devices) · 2024-06-26
- HighPantoprazole Sodium for Injection Recalled Due to Sterility Concern
FDA (Drugs) · 2023-09-20